SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001192482-18-000160
Filing Date
2018-04-16
Accepted
2018-04-16 16:15:04
Documents
2
Period of Report
2018-04-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 1572
2 POA poabutlerr.htm EX-24 3071
  Complete submission text file 0001192482-18-000160.txt   6131
Mailing Address C/O RELYPSA, INC. 700 SAGINAW DR. REDWOOD CITY CA 94063
Business Address
Butler John P. (Reporting) CIK: 0001591467 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37526 | Film No.: 18756774

Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Issuer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations